Statistics

Total Visits

Views
FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ?3 circulating tumour cells: the randomised phase III VISNÚ-1 trial90

File Visits

Downloads
35923-233.pdf25

Select a period of time:

Number of views in the range

Views
FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ?3 circulating tumour cells: the randomised phase III VISNÚ-1 trial40

Number of downloads in the range

Downloads
35923-233.pdf5

Views

Views
April 202513
May 20255
June 20253
July 202511
August 20251
September 20256
October 20251
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • April 2025
    2
  • May 2025
    0
  • June 2025
    0
  • July 2025
    1
  • August 2025
    2
  • September 2025
    0
  • October 2025
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
Hong Kong11
United States9
Brazil9
United Kingdom3
Germany2
Mexico2
Austria2
Ecuador1
Singapore1
 

Top countries by downloads

Downloads
Hong Kong2
United States2
Mexico1
 

Top cities views

Views
Hong Kong11
Nuremberg2
Columbus2
Ananindeua1
Brasília1
Charlotte1
Council Bluffs1
Cramlington1
Dallas1
Feliz1
 

Top cities by downloads

Downloads
Hong Kong2